-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Monopar Therapeutics quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q3 2024.
- Monopar Therapeutics Return On Equity for the quarter ending September 30, 2024 was -107 %, a 5.16% increase year-over-year.
- Monopar Therapeutics annual Return On Equity for 2023 was -116 %, a 49.1% decline from 2022.
- Monopar Therapeutics annual Return On Equity for 2022 was -77.8 %, a 89.4% decline from 2021.
- Monopar Therapeutics annual Return On Equity for 2021 was -41.1 %, a 6% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)